SCHEMBL4773404

SCHEMBL4773404

Nc1ccc2c(c1)OC(N)CO2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 4/20 0.50
CHRNA3 P32297 4/20 0.50
CHRNB2 P17787 1/20 0.50
CHRNA4 P43681 1/20 0.50
MAPT P10636 4/20 0.47
KDM4E B2RXH2 2/20 0.47
GAA P10253 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
RAB9A P51151 1/20 0.39
MAPK1 P28482 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
MITF O75030 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP19A1 P11511 2/20 0.36
CA2 P00918 2/20 0.33
TRPM8 Q7Z2W7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21198157 0.77 CHRNB4 (0.47) CHRNB4CHRNA3CHRNB2CHRNA4MAPT
SCHEMBL1890902 0.75 NISCH (0.53) CA2
SCHEMBL3586040 0.75 CHRNB4 (0.46) CHRNB4CHRNA3CHRNB2CHRNA4MAPT
SCHEMBL21198154 0.75 NISCH (0.46) CHRNB4CHRNA3CHRNB2CHRNA4MAPT
SCHEMBL3766653 0.74 RPS6KB2 (0.46) CHRNB4CHRNA3CHRNB2CHRNA4MAPT
SCHEMBL658161 0.72 CHRNB4 (0.52) CHRNB4CHRNA3CHRNB2CHRNA4MAPT
SCHEMBL5937114 0.72 CHRNB4 (0.46) CHRNB4CHRNA3CHRNB2CHRNA4MAPT
SCHEMBL5582716 0.72 CA2 (0.48) CHRNB4CHRNA3CHRNB2CHRNA4MAPT
SCHEMBL27682747 0.71 MAPT (0.39) CHRNB4CHRNA3CHRNB2CHRNA4MAPT
SCHEMBL26726922 0.71 MAPT (0.40) CHRNB4CHRNA3CHRNB2CHRNA4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957078-A2 PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER THROUGH INHIBITION OF AURORA KINASE Bayer Healthcare, LLC (US) 2008-08-20 EP disclosed
WO-2007064932-A2 PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER THROUGH INHIBITION OF AURORA KINASE BAYER HEALTHCARE LLC. (US) 2007-06-07 WO disclosed